Role of redox-regulated transcription factors in inflammation, aging and age-related diseases

Experimental Gerontology

Volumn 35, Issue 5, 2000, Pages 521-532

  Lavrovsky, Y ^a   Chatterjee, B ^a,b   Clark, R A ^a,b   Roy, A K ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

Author keywords

Atherosclerosis; Nuclear factor kappa B; Peroxisome proliferator

Indexed keywords

CELL NUCLEUS RECEPTOR; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PREGNANCY SPECIFIC BETA1 GLYCOPROTEIN; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1;

AGING; ARTHRITIS; ATHEROSCLEROSIS; GENE CONTROL; GENE EXPRESSION; HUMAN; INFLAMMATION; NONHUMAN; OXIDATION REDUCTION POTENTIAL; OXIDATIVE STRESS; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SHORT SURVEY; SIGNAL TRANSDUCTION;

EID: 0034253463     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0531-5565(00)00118-2     Document Type: Review

References (57)

1. Ahmad M., Marui N., Alexander R.W., Medford R.M. Cell type-specific transactivation of the VCAM-1 promoter through an NF-kappa B enhancer motif. J. Biol. Chem. 270:1995;8976-8983.
2. Aizawa T., Ishizaka N., Taguchi J., Nagai R., Mori I., Tang S.S., Ingelfinger J.R., Ohno M. Heme oxygenase-1 is upregulated in the kidney of angiotensin II-induced hypertensive rats: possible role in renoprotection. Hypertension. 35:2000;800-806.
3. Ammendola R., Mesuraca M., Russo T., Cimino F. The DNA-binding efficiency of Sp1 is affected by redox changes. Eur. J. Biochem. 225:1994;483-489.
4. Baeuerle P.A., Baltimore D. NF-kappa B: ten years after. Cell. 87:1996;13-20.
5. Banfi B., Maturana A., Jaconi S., Arnaudeau S., Laforge T., Sinha B., Ligeti E., Demaurex N., Krause K.H. A mammalian H+ channel generated through alternative splicing of the NADPH oxidase homolog NOH-1. Science. 287:2000;138-142.
6. Barlow C., Dennery P.A., Shigenaga M.K., Smith M.A., Morrow J.D., Roberts L.J., Wynshaw-Boris A., Levine R.L. Loss of the ataxia-telangiectasia gene product causes oxidative damage in target organs. Proc. Natl. Acad. Sci., USA. 96:1999;9915-9919.
7. Beckman K.B., Ames B.N. The free radical theory of aging matures. Physiol. Rev. 78:1998;547-581.
8. Bierhaus A., Ziegler R., Nawroth P.P. Molecular mechanisms of diabetic angiopathy - clues for innovative therapeutic interventions. Horm. Res. 50:1998;1-5.
9. Clark R.A. Activation of the neutrophil respiratory burst oxidase. J. Infect. Dis. 179:1999;S309-S317.
10. Collart F.R., Horio M., Huberman E. Heterogeneity in c-jun gene expression in normal and malignant cells exposed to either ionizing radiation or hydrogen peroxide. Radiat. Res. 142:1995;188-196.
11. Commoner B., Townsend J., Pake G.E. Free radicals in biological materials. Nature. 174:1954;689-691.
12. Cross A.R., Curnutte J.T., Heyworth P.G. Hematologically important mutations: the autosomal recessive forms of chronic granulomatous disease. Blood Cells Mol. Dis. 22:1996;268-270.
13. Devchand P.R., Keller H., Peters J.M., Vazquez M., Gonzalez F.J., Wahli W. The PPARalpha-leukotriene B4 pathway to inflammation control. Nature. 384:1996;39-43.
14. Dong Z., Lavrovsky Y., Venkatachalam M.A., Roy A.K. Heme oxygenase-1 in tissue patology: The Yin and Yang. Am. J. Pathol. 156:2000;1485-1488.
15. Galien R., Garcia T. Estrogen receptor impairs interleukin-6 expression by preventing protein binding on the NF-kappaB site. Nucleic Acids Res. 25:1997;2424-2429.
16. Harman D. Aging: a theory based on free radical and radiation chemistry. J. Gerontol. 2:1956;298-300.
17. Ho E., Bray T.M. Antioxidants NF-κB activation, and diabetogenesis. Proc. Soc. Exp. Biol. Med. 222:1999;205-213.
18. Iijima N., Tamada Y., Hayashi S., Tanaka M., Ishihara A., Hasegawa M., Ibata Y. Expanded expression of heme oxygenase-1 (HO-1) in the hypothalamic median eminence of aged as compared with young rats: an immunocytochemical study. Neurosci. Lett. 271:1999;113-116.
19. Janssen Y.M.W., Heintz N.H., Mossman B.T. Induction of c-fos and c-jun proto-oncogene expression by abeistos is ameliorated by N-acetyl-cysteine in mesotheliail cells. Cancer Res. 55:1995;2085-2089.
20. Karin M. New twists in gene regulation by glucocorticoid receptor: is DNA binding dispensable? Cell. 93:1998;487-490.
21. Kerppola T., Curran T. Transcription. Zen and the art of Fos and Jun. Nature. 373:1995;199-200.
22. Khan B.V., Parthasarathy S.S., Alexander R.W., Medford R.M. Modified low density lipoprotein and its constituents augment cytokine-activated vascular cell adhesion molecule-1 gene expression in human vascular endothelial cells. J. Clin. Invest. 95:1995;1262-1270.
23. Laragh, J.H., Brenner, B.M., 1995. Hypertension: Pathophysiology, Diagnosis, and Management, 2nd ed.
24. Lavrovsky Y., Song C.S., Chatterjee B., Roy A.K. Age-dependent increase of heme oxygenase-1 gene expression in the liver mediated by NFkappaB. Mech. Ageing Dev. 114:2000;49-60.
25. Lee A.C., Fenster B.E., Ito H., Takeda K., Bae N.S., Hirai T., Yu Z.X., Ferrans V.J., Howard B.H., Finkel T. J. Biol. Chem. 274:1999;7936-7940.
26. Lehmann J.M., Lenhard J.M., Oliver B.B., Ringold G.M., Kliewer S.A. Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs. J. Biol. Chem. 272:1997;3406-3410.
27. Lentsch A.B., Shanley T.P., Sarma V., Ward P.A. In vivo suppression of NF-kappa B and preservation of I kappa B alpha by interleukin-10 and interleukin-13. J. Clin. Invest. 100:1997;2443-2448.
28. Maines M.D. The heme oxygenase system: a regulator of second messenger gases. Annu. Rev. Pharmacol. Toxicol. 37:1997;517-554.
29. Marui N., Offermann M.K., Swerlick R., Kunsch C., Rosen C.A., Ahmad M., Alexander R.W., Medford R.M. Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells. J. Clin. Invest. 92:(4):1993;1866-1874.
30. McCord J.M., Fridovich I. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J. Biol. Chem. 244:1969;6049-6055.
31. McKay L.I., Cidlowski J.A. Molecular control of immune/inflammatory responses: interactions between nuclear factor-kappa B and steroid receptor-signaling pathways. Endocr. Rev. 20:1999;435-459.
32. Nath K.A., Haggard J.J., Croatt A.J., Grande J.P., Poss K.D., Alam J. The indispensability of heme oxygenase-1 (HO-1) in protecting against acute heme protein-induced toxicity in vivo. Am. J. Pathol. 156:2000;1527-1535.
33. Newman P.J. The biology of PECAM-1. J. Clin. Invest. 99:1997;3-8.
34. Okamoto K., Tanaka H., Ogawa H., Makino Y., Eguchi H., Hayashi S., Yoshikawa N., Poellinger L., Umesono K., Makino I. Redox-dependent regulation of nuclear import of the glucocorticoid receptor. J. Biol. Chem. 274:1999;10363-10371.
35. Pagano P.J., Clark J.K., Cifuentes-Pagano M.E., Clark S.M., Callis G.M., Quinn M.T. Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia: enhancement by angiotensin II. Proc. Natl. Acad. Sci., USA. 94:1997;14483-14488.
36. Palvimo J.J., Reinikainen P., Ikonen T., Kallio P.J., Moilanen A., Janne O.A. Mutual transcriptional interference between RelA and androgen receptor. J. Biol. Chem. 271:1996;24151-24156.
37. Poelzl G., Kasai Y., Mochizuki N., Shaul P.W., Brown M., Mendelsohn M.E. Specific association of estrogen receptor beta with the cell cycle spindle assembly checkpoint protein MAD2. Proc. Natl. Acad. Sci., USA. 97:2000;2836-2839.
38. Poynter M.E., Daynes R.A. Peroxisome proliferator-activated receptor alpha activation modulates cellular redox status, represses nuclear factor-kappaB signaling, and reduces inflammatory cytokine production in aging. J. Biol. Chem. 273:1998;32833-32841.
39. Ray A., Prefontaine K.E. Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor. Proc. Natl. Acad. Sci., USA. 91:1994;752-756.
40. Ricote M., Li A.C., Willson T.M., Kelly C.J., Glass C.K. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature. 391:1998;79-82.
41. Rippe R.A., Schrum L.W., Stefanovic B., Solis-Herruzo J.A., Brenner D.A. NF-kappaB inhibits expression of the alpha1(I) collagen gene. DNA Cell Biol. 18:1999;751-761.
42. Roebuck K.A. Oxidant stress regulation of IL-8 and ICAM-1 gene expression: differential activation and binding of the transcription factors AP-1 and NF-kappaB. Int. J. Mol. Med. 4:1999;223-230.
43. Rosenfeld M.E. Inflammation, lipids, and free radicals: lessons learned from the atherogenic process. Semin. Reprod. Endocrinol. 16:1998;246-261.
44. Roy A.K. Transcription factors and aging. Mol. Med. 3:1997;496-504.
45. Schreck R., Rieber P., Baeuerle P.A. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J. 10:1991;2247-2258.
46. Sohal R.S. Role of mitochondria and oxidative stress in the aging process. Beal M.F., Howell N., Bodis-Wollner I. Mitochondria and Free Radicals in Neurodegenerative Diseases. 1997;91-107 Wiley, New York.
47. Spencer N.F., Poynter M.E., Im S.Y., Daynes R.A. Constitutive activation of NF kappa B in an animal model of aging. Int. Immunol. 9:1997;1581-1588.
48. Spiegelman B.M., Flier J.S. Adipogenesis and obesity: rounding out the big picture. Cell. 87:1996;377-389.
49. Stadtman E.R. Protein oxidation and aging. Science. 257:1992;1220-1224.
50. Suh Y.A., Arnold R.S., Lassegue B., Shi J., Xu X., Sorescu D., Chung A.B., Griendling K.K., Lambeth J.D. Cell transformation by the superoxide-generating oxidase Mox1. Nature. 401:1999;79-82.
51. Supakar P.C., Jung M.H., Song C.S., Chatterjee B., Roy A.K. Nuclear factor kappa B functions as a negative regulator for the rat androgen receptor gene and NF-kappa B activity increases during the age-dependent desensitization of the liver. J. Biol. Chem. 270:1995;837-842.
52. Toliver-Kinsky T., Papaconstantinou J., Perez-Polo J.R. Age-associated alterations in hippocampal and basal forebrain nuclear factor kappa B activity. J. Neurosci. Res. 48:1997;580-587.
53. Tontonoz P., Nagy L., Alvarez J.G., Thomazy V.A., Evans R.M. PPARγpromtes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell. 93:1998;241-252.
54. Verma I.M., Stevenson J. IkappaB kinase: beginning, not the end. Proc. Natl. Acad. Sci., USA. 94:1997;11758-11760.
55. Wu X., Bishopric N.H., Discher D.J., Murphy B.J., Webster K.A. Physical and functional sensitivity of zinc finger transcription factors to redox change. Mol. Cell. Biol. 16:1996;1035-1046.
56. Xanthoudakis S., Curran T. Redox regulation of AP-1: a link between transcription factor signaling and DNA repair. Adv. Exp. Med. Biol. 387:1996;69-75.
57. Yla-Herttuala S. Oxidized LDL and artherogenesis. Ann. N.Y. Acad. Sci. 874:1999;134-137.